Early combination therapy after heart attack reduces risk of recurrence and death
Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...
Tag: Cardiology
Pregnancy complications may predict future heart disease risk
Complications during pregnancy (or adverse pregnancy outcomes), like gestational diabetes and newly developed high blood pressure, act as nature's stress ...
High cholesterol may not signal heart disease risk in metabolically healthy people
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, in collaboration with researchers across multiple institutions, has published a new ...
Early warning signs may help prevent sudden arrhythmic death syndrome
Recognizing and detecting the signs that commonly precede sudden arrhythmic death syndrome (SADS) may help to prevent premature deaths, according ...
Women with pre-eclampsia face early onset of cardiovascular risk factors
Women who have experienced pre-eclampsia have accelerated accumulation of cardiovascular (CV) risk factors compared with women who had pregnancies without ...
Compound heatwaves linked to increased cardiac deaths
Cardiac deaths increase significantly during compound heatwaves-heatwaves where temperatures are elevated both during the day and overnight-according to a new ...
Fluid restriction does not improve health in heart failure patients
People with heart failure have long been advised to limit the amount of fluids they consume each day to help ...
WARRIOR trial finds no impact of intensive therapy on heart events in women
An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events at five years ...
Microplastics exposure linked to increased risk of chronic diseases
Tiny fragments of plastic have become ubiquitous in our environment and our bodies. Higher exposure to these microplastics, which can ...
Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...